Skip to content

    Diabetes Health Center

    Font Size
    A
    A
    A

    FDA Panel: Keep Avandia on Market

    Recommendation Made Despite Concerns That Diabetes Drug Boosts Heart Attack Risk
    By
    WebMD Health News
    Reviewed by Louise Chang, MD

    July 30, 2007 -- An FDA advisory panel said Monday the diabetes drug Avandia should remain on the U.S. market, despite widespread concerns that it raises the risk of heart attacks.

    Experts overwhelmingly expressed confidence that the drug, also called rosiglitazone, boosts the risk of heart attack and other dangerous heart problems. But they then voted 22-1 to urge the FDA to allow continued sales to U.S. patients.

    But those continued sales are likely to carry significant new warnings about who can safely use Avandia. Several experts said the FDA should consider either stark new "black box" warnings on Avandia or other restrictions that could limit its availability in patients with heart disease.

    "We certainly sent I think a clear signal that there's going to be changes in the way this is promoted ... and certainly in how physicians use this drug," Clifford Rosen, MD, the panel's leader, said after the decision.

    Safety Warnings

    The decision came despite calls from some FDA officials to pull Avandia from the U.S. market.

    "A wrong decision will cost thousands of lives," said David Graham, MD, an FDA safety officer who urged Avandia be removed.

    But officials from GlaxoSmithKline, Avandia's manufacturer, pointed out that no studies had shown that patients taking Avandia were more likely to die of heart problems than those taking another drug or a placebo.

    "These data tell us that those events aren't resulting in excess mortality," said Ronald Krall, MD, the company's chief medical officer.

    Keeping Options Available

    Experts ultimately said they were worried about taking Avandia away as an option for patients when it is still possible that many may benefit from it.

    "To perform a draconian type of operation on this medication probably would not be advisable in the long run, said David S. Schade, MD, a professor of medicine at the University of New Mexico School of Medicine and a member of the advisory panel.

    Avandia is an oral medication used by patients with type 2 diabetes to help control blood sugar. Millions of patients have taken Avandia, as well as a similar drug called Actos, or pioglitazone.

    Today on WebMD

    Diabetic tools
    Symptoms, diagnosis, treatment, and more.
    woman flexing muscles
    10 strength training exercises.
     
    Blood sugar test
    12 practical tips.
    Tom Hanks
    Stars living with type 1 or type 2.
     
    kenneth fujioka, md
    Video
    Can Vinegar Treat Diabetes
    Article
     
    Middle aged person
    Tool
    jennie brand miller
    Video
     

    Prediabetes How to Prevent Type 2 Diabetes
    Article
    type 2 diabetes
    Slideshow
     
    food fitness planner
    Tool
    feet
    Slideshow